OTC Markets OTCPK - Delayed Quote USD

Scopus BioPharma Inc. (SCPS)

Compare
0.0003 0.0000 (0.00%)
At close: December 30 at 7:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
9,343.0140
11,714.8770
27,634.6190
10,155.8460
Operating Income
-9,343.0140
-11,714.8770
-27,634.6190
-10,155.8460
Net Non Operating Interest Income Expense
--
--
-774.6790
-706.4460
Other Income Expense
--
--
1,455.8890
--
Pretax Income
-9,343.0140
-11,714.8770
-26,953.4090
-10,862.2920
Net Income Common Stockholders
-8,695.8240
-11,609.8270
-26,953.4090
-10,862.2920
Diluted NI Available to Com Stockholders
-8,695.8240
-11,609.8270
-26,953.4090
-10,862.2920
Basic EPS
-0.31
-0.55
-1.56
-0.81
Diluted EPS
-0.31
-0.55
-1.56
-0.81
Basic Average Shares
28,088.1040
21,094.2640
17,252.3910
13,362.9590
Diluted Average Shares
28,088.1040
21,094.2640
17,252.3910
13,362.9590
Total Operating Income as Reported
--
-11,714.8770
-27,634.6190
-10,155.8460
Total Expenses
9,343.0140
11,714.8770
27,634.6190
10,155.8460
Net Income from Continuing & Discontinued Operation
-8,695.8240
-11,609.8270
-26,953.4090
-10,862.2920
Normalized Income
-8,695.8240
-11,609.8270
-28,409.2980
-10,862.2920
Interest Expense
--
--
774.6790
706.4460
Net Interest Income
--
--
-774.6790
-706.4460
EBIT
-9,343.0140
-11,714.8770
-26,178.7300
-10,155.8460
EBITDA
-9,341.9120
-11,713.1490
-26,177.2300
-10,154.4060
Reconciled Depreciation
1.1020
1.7280
1.5000
1.4400
Net Income from Continuing Operation Net Minority Interest
-8,695.8240
-11,609.8270
-26,953.4090
-10,862.2920
Total Unusual Items Excluding Goodwill
--
--
1,455.8890
--
Total Unusual Items
--
--
1,455.8890
--
Normalized EBITDA
-9,341.9120
-11,713.1490
-27,633.1190
-10,154.4060
12/31/2020 - 12/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZURA Zura Bio Limited
2.5000
-1.96%
 
RLMD Relmada Therapeutics, Inc.
0.5200
+13.29%
 
BMEA Biomea Fusion, Inc.
3.8800
0.00%
 
NNVC NanoViricides, Inc.
1.4300
-4.03%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.6507
-6.68%
 
ENSC Ensysce Biosciences, Inc.
8.14
-5.57%
 
VRAX Virax Biolabs Group Limited
2.2500
+9.22%
 
GOVX GeoVax Labs, Inc.
2.4700
+1.23%
 
PLRZ Polyrizon Ltd.
2.1700
+0.46%
 
MESO Mesoblast Limited
19.80
-5.89%